Article
Understanding the action of INH on a highly INH-resistant Mycobacterium tuberculosis strain using Genechips.
Tuberculosis (Edinburgh, Scotland) - 1 Jan 2007
Fu Li M, Shinnick Thomas M
Abstract excerpt
The availability of the complete sequence of Mycobacterium tuberculosis genome coupled with microarray technology has enabled a high-throughput approach to the pharmacogenomics of this organism. Isoniazid (INH) is a first-line drug for the treatment of tuberculosis and the microarray approach has generated new insight into the action of INH on a drug-susceptible strain. It has also shown that INH does not induce...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
